| Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases M Tadolini, LR Codecasa, JM García-García, FX Blanc, S Borisov, ... European Respiratory Journal 56 (1), 2020 | 492 | 2020 |
| Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement LC Christoph Lange, Ibrahim Abubakar, Jan-Willem C european respiratory journal, 2014 | 425 | 2014 |
| Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR-and XDR-TB: a multicentre study SE Borisov, K Dheda, M Enwerem, RR Leyet, L D'Ambrosio, R Centis, ... European Respiratory Journal 49 (5), 2017 | 368 | 2017 |
| Clinical and operational value of the extensively drug-resistant tuberculosis definition GB Migliori, G Besozzi, E Girardi, K Kliiman, C Lange, OS Toungoussova, ... European Respiratory Journal 30 (4), 623-626, 2007 | 279 | 2007 |
| Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open … DE Griffith, G Eagle, R Thomson, TR Aksamit, N Hasegawa, K Morimoto, ... American journal of respiratory and critical care medicine 198 (12), 1559-1569, 2018 | 275 | 2018 |
| Risk assessment of tuberculosis in immunocompromised patients. A TBNET study. American journal of respiratory and critical care medicine 190 (10), 1168-76, 2014 | 272 | 2014 |
| Use of a T-cell interferon-γ release assay for the diagnosis of tuberculous pleurisy M Losi, A Bossink, L Codecasa, C Jafari, M Ernst, S Thijsen, D Cirillo, ... European Respiratory Journal 30 (6), 1173-1179, 2007 | 243 | 2007 |
| Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis A Bandera, A Gori, L Catozzi, AD Esposti, G Marchetti, C Molteni, ... Journal of clinical microbiology 39 (6), 2213-2218, 2001 | 236 | 2001 |
| Worldwide effects of coronavirus disease pandemic on tuberculosis services, January–April 2020 GB Migliori, PM Thong, O Akkerman, JW Alffenaar, F Álvarez-Navascués, ... Emerging infectious diseases 26 (11), 2709, 2020 | 227 | 2020 |
| Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report S Borisov, E Danila, A Maryandyshev, M Dalcolmo, S Miliauskas, L Kuksa, ... European Respiratory Journal 54 (6), 2019 | 187 | 2019 |
| Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases. GB Migliori, C Lange, R Centis, et al Eur Respir J 31 (6), 1155-59, 2008 | 187 | 2008 |
| Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients F Piana, LR Codecasa, P Cavallerio, M Ferrarese, GB Migliori, ... European Respiratory Journal 28 (1), 31-34, 2006 | 175 | 2006 |
| First evaluation of QuantiFERON-TB Gold Plus performance in contact screening L Barcellini, E Borroni, J Brown, E Brunetti, D Campisi, PF Castellotti, ... European respiratory journal 48 (5), 1411-1419, 2016 | 170 | 2016 |
| Challenges and perspectives in the diagnosis of extrapulmonary tuberculosis L Norbis, R Alagna, E Tortoli, LR Codecasa, GB Migliori, DM Cirillo Expert review of anti-infective therapy 12 (5), 633-647, 2014 | 160 | 2014 |
| Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study et al Giovanni Battista Migliori, Pei Min Thong, Jan-Willem Alffenaar ... Eur Respir J, 2021 | 152 | 2021 |
| Risk assessment of tuberculosis in contacts by IFN-γ release assays. A Tuberculosis Network European Trials Group study JP Zellweger, G Sotgiu, M Block, S Dore, N Altet, R Blunschi, M Bogyi, ... American journal of respiratory and critical care medicine 191 (10), 1176-1184, 2015 | 141 | 2015 |
| Clinical standards for the assessment, management and rehabilitation of post-TB lung disease GB Migliori, FM Marx, N Ambrosino, E Zampogna, HS Schaaf, ... The International Journal of Tuberculosis and Lung Disease 25 (10), 797-813, 2021 | 135 | 2021 |
| Tuberculosis and COVID-19 co-infection: description of the global cohort TB/COVID-19 Global Study Group European Respiratory Journal 59 (3), 2022 | 128 | 2022 |
| First independent evaluation of QuantiFERON-TB Plus performance L Barcellini, E Borroni, J Brown, E Brunetti, L Codecasa, F Cugnata, ... European Respiratory Journal 47 (5), 1587-1590, 2016 | 123 | 2016 |
| ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid use S Esposito, L D’Ambrosio, M Tadolini, HS Schaaf, JC Luna, B Marais, ... European Respiratory Journal 44 (3), 811-815, 2014 | 120 | 2014 |
Maurizio FerrareseMedicoVerificeret mail på ospedaleniguarda.it
